Request for Covid-19 Impact Assessment of this Report
Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.
This new study focuses on industry trends and forecasts with historical data (2008, 2013 and 2018) and long-term forecasts through 2023 and 2028 are presented.
The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases.
Asia Market Info & Dev Co. is one of the leading sources for up-to-date market information and research on the fastest-growing Chinese markets. We have published over 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our publications are intended to help international marketers identify business opportunities and promote their product sales in the Chinese markets.
I. INTRODUCTION
Report Scope and Methodology
Executive Summary
II. BUSINESS ENVIRONMENT
Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties
Market Trends
Technology Development
Market Development
Major Industry Development
Regional Development
Enterprise Development
Labor Market Development
IV. OSTEOPOROSIS DRUGS PRODUCTION AND DEMAND
Overview
Osteoporosis Drugs Production and Demand
Calcium Drugs
Supply and Demand
Major Manufacturers
Bisphosphonate Drugs
Supply and Demand
Major Manufacturers
Calcitonin Drugs
Supply and Demand
Major Manufacturers
Estrogen Drugs
Supply and Demand
Major Manufacturers
Osteoporosis Drugs Import and Export
LIST OF TABLES
I. INTRODUCTION
Economic Outlook Summary
II. BUSINESS ENVIRONMENT
Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade
IV. OSTEOPOROSIS DRUGS PRODUCTION AND DEMAND
China's Osteoporosis Drugs Sales Volume and Market Share by Class
China's Major Calcium Drugs Market Share by Kind
China’s Major Calcium Drugs Manufacturers
China's Major Bisphosphonate Drugs Market Share by Kind
China’s Major Bisphosphonate Drugs Manufacturers
China's Major Calcitonin Drugs Market Share by Kind
China’s Major Calcitonin Drugs Manufacturers
China's Major Estrogen Drugs Market Share by Kind
China’s Major Estrogen Drugs Manufacturers
China’s Osteoporosis Drugs Import Volume by Country
China’s Osteoporosis Drugs Export Volume by Country
LIST OF CHARTS
I. INTRODUCTION
China’s Osteoporosis Drugs Sales Volume
China’s Major Class of Osteoporosis Drugs
II. BUSINESS ENVIRONMENT
China’s GDP and Growth Rate
Industrial Output by Ownership
China’s Imports and Exports
IV. OSTEOPOROSIS DRUGS PRODUCTION AND DEMAND
China’s Osteoporosis Drugs Sales Volume
China's Major Class of Osteoporosis
China's Osteoporosis Drugs Sales Volume and Market Share by Class
China’s Calcium Drugs Sales Volume
China's Major Calcium Drugs Market Share by Kind
China’s Bisphosphonate Drugs Sales Volume
China's Major Bisphosphonate Drugs Market Share by Kind
China’s Calcitonin Drugs Sales Volume
China's Major Calcitonin Drugs Market Share by Kind
China’s Estrogen Drugs Sales Volume
China's Major Estrogen Drugs Market Share by Kind
China’s Osteoporosis Drugs Import Volume
China’s Osteoporosis Drugs Import Volume by Country
China’s Osteoporosis Drugs Export Volume
China’s Osteoporosis Drugs Import and Export
China’s Osteoporosis Drugs Export Volume by Country
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...